|
|
 |
Pulse Rate Determination with Certain Drugs |
|
Manual: Hospice Policy and Procedure Manual (Ver 4) External Reference: (TJC: MM.5.10)(COP: §418.96(c))
As the health care industry’s most comprehensive library of customizable policy and procedure templates, MCN Healthcare’s Hospice Policy and Procedure Manual includes this customizable template, Pulse Rate Determination with Certain Drugs. MCN’s policy library helps you meet compliance with Joint Commission and federal regulations including CMS, CDC, OSHA, OIG, HIPAA and more. Health care organizations around the world utilize MCN’s compliant ready templates and workflow process tools to help them meet the latest changes in regulations and standards. Here is some sample content from Pulse Rate Determination with Certain Drugs:
| | PURPOSE:
To delineate the process for determining the pulse rate for certain drugs.
POLICY #1:
The apical pulse rate will be measured and recorded prior to administration of the following drugs:
GenericTrade NameAcebutololSectralAtenololTenorminDigitoxinCrystodiginDigoxinLanoxinMetoprololLopressorNadololCorgardPindololViskenPropranololInderalTimololBlocadren/Betoptic
Rationale:
Digital glycosides and beta blocking agents can slow the heart rate by means of their effects on the sinus node pacemaker and the AV atrioventricular nodes of the heart. The apical heart rate can aid in assessing... |
| Second excerpt: |
| | ...pressure. The response is most apt to occur when a nitrate product used is initiated or after a dose has been increased. The patient may monitor the heart rate when such a drug is started or when a dose is increased. This will help to see how the patient tolerates the drug.
PROCEDURE FOR POLICY #2:
Apical pulse rates will be measured and recorded following the administration of the identified medications.
For the first week after an oral or topical nitroglycerin product is initiated,... |
|
Back to Hospice Policy and Procedure Manual (Ver 4) |
|
|
|
|